AstraZeneca PLC Ordinary Shares (AZN)

Capital Expenditure

-$5.07B

TTM · Period ending: · USD

AZN logo

AZN Capital Expenditure

Latest reported-$5.07B
AZN TTM CapEx (-$636.08M → -$5.07B)
High-resolution chart · PNG

AZN capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-632,640,262
-685,344,538
-636,082,443
-1,224,729,265
-1,557,729,265
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.